Progestogen safety and tolerance in hormonal replacement therapy

@article{Palacios2016ProgestogenSA,
  title={Progestogen safety and tolerance in hormonal replacement therapy},
  author={S. Palacios and A. Mej{\'i}a},
  journal={Expert Opinion on Drug Safety},
  year={2016},
  volume={15},
  pages={1515 - 1525}
}
ABSTRACT Introduction: Today, it is a mandatory practice to prescribe a combination of estrogens and progestogens for menopausal women requiring hormone therapy and with a uterus. The WHI study and its reanalysis demonstrate a big difference in results between the conjugated equin estrogen (CEE) only vs.CEE plus medroxyprogesterone acetate (MPA) arms in relation with breast cancer and cardiovascular risk. The conclusion is that risk is clearly higher in the arm with MPA than in the CEE only arm… Expand
View on Taylor & Francis
ncbi.nlm.nih.gov
12 Citations
Background Citations
3

12 Citations

Citation Type

Citation Type

Progestogens as a component of menopausal hormone therapy: the right molecule makes the difference
What do TSECs provide in the menopausal hormone therapy?
  • P. Llaneza, J. Calaf, +5 authors D. Lubian
  • Medicine
  • Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology
  • 2018
Efficacy of progestin-only treatment for the management of menopausal symptoms: a systematic review.
Safety and benefit considerations for menopausal hormone therapy
Hormone Therapy and Effects on Sporadic Alzheimer's Disease in Postmenopausal Women: Importance of Nomenclature.
Hormone therapy for first-line management of menopausal symptoms: Practical recommendations
Hormone Replacement Therapy in a Patient with Hypogonadism and Coexisting Medical Conditions
High progesterone levels are associated with family history of premature coronary artery disease in young healthy adult men
New insights of CYP1A in endogenous metabolism: a focus on single nucleotide polymorphisms and diseases
Gestagengabe in der Menopause: Was sind Unterschiede, Vorteile und Nachteile der einzelnen Präparate?
...
1
2
...

References

SHOWING 1-10 OF 114 REFERENCES
Progestogens used in postmenopausal hormone therapy: differences in their pharmacological properties, intracellular actions, and clinical effects.
Are the progestins responsible for breast cancer risk during hormone therapy in the postmenopause?: Experimental vs. clinical data
  • H. Seeger, A. Mueck
  • Medicine
  • The Journal of Steroid Biochemistry and Molecular Biology
  • 2008
Role of progestogen in hormone therapy for postmenopausal women: position statement of The North American Menopause Society.
Drospirenone and estradiol: a new option for the postmenopausal woman
  • D. Archer
  • Medicine
  • Climacteric : the journal of the International Menopause Society
  • 2007
Controversies concerning the safety of estrogen replacement therapy
Progestin may modify the effect of low-dose hormone therapy on mammographic breast density
Potency of progestogens used in hormonal therapy: Toward understanding differential actions
The levonorgestrel intrauterine system in menopausal hormone replacement therapy: five-year experience.
Estrogen plus progestin and the risk of coronary heart disease.
Symptom Relief and Side Effects of Postmenopausal Hormones: Results From the Postmenopausal Estrogen/Progestin Interventions Trial
...
1
2
3
4
5
...